University of California-Berkeley · ChemistryNomura Drug Discovery Lab
Daniel Nomura · Berkeley, California
Research Focus
The Nomura Research Group at UC Berkeley is dedicated to discovering new cancer treatments by addressing the challenge of 'undruggable' proteins that do not have known binding sites. They are developing innovative technologies and methodologies to create next-generation therapies that can target these difficult proteins. The lab combines advanced techniques in chemistry and biotechnology to explore how these proteins can be therapeutically manipulated for cancer therapies.
cancer therapychemoproteomicsdrug discoveryundruggable proteinsinnovative technologiesnovel therapeuticstargeted treatment
Research Aims
5AIM 01Develop innovative chemoproteomic platforms to identify potential drugs.
AIM 02Investigate new therapeutic modalities to target undruggable cancer proteins.
AIM 03Advance technologies to enhance ligand discovery for cancer treatment.
AIM 04Reimagine the concept of druggability in the context of the cancer proteome.
AIM 05Create next-generation therapies aimed at improving cancer patient outcomes.
Skills the Lab Values
chemoproteomicsprotein binding assaysdrug development techniqueshigh-throughput screeningcell culturebiochemical assaysmass spectrometrydata analysis in drug discoveryligand discovery techniques
Output against the department
Publications288top 39% of dept.84th of 216
this lab
most publishedleast published
Citations26ktop 16% of dept.35th of 216
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.